Skip to main content
Philip Norris, MD, Infectious Disease, San Francisco, CA, Zuckerberg San Francisco General Hospital and Trauma Center

PhilipJohnNorrisMD

Infectious Disease San Francisco, CA

Professor, Laboratory Medicine and Medicine, UCSF School of Medicine

Dr. Norris is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Norris' full profile

Already have an account?

  • Office

    Vitalant Research Institute
    270 Masonic Avenue
    San Francisco, CA 94118
    Phone+1 415-923-5769
    Fax+1 415-567-5899
  • Is this information wrong?

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1998 - 2001
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1996 - 1998
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Internship, Internal Medicine, 1995 - 1996
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1995

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2026
  • MA State Medical License
    MA State Medical License 1998 - 2005
  • NC State Medical License
    NC State Medical License 1996 - 1999
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effects of Blood Storage Age on Immune, Coagulation, and Nitric Oxide Parameters in Transfused Patients Undergoing Cardiac Surgery  
    Philip J Norris, Philip C Spinella, Jerrold H Levy, Marie E Steiner, Transfusion
  • Prevalence and Risk Factors for RBC Alloantibodies in Blood Donors in the Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III)  
    Matthew S Karafin, Darrell J Triulzi, Ronald G Hauser, Philip J Norris, Jeanne E Hendrickson, Jerome L Gottschall, Christopher A Tormey, Nareg H Roubinian, Transfusion

Press Mentions

  • Could a Blood Test for Coronavirus Antibodies Get California Back to Normal? Lots of Questions Remain
    Could a Blood Test for Coronavirus Antibodies Get California Back to Normal? Lots of Questions RemainApril 8th, 2020

Grant Support

  • Properties Of Stored Rbcs: Minimization Of Immune And Vascular ReactivityNational Heart, Lung, And Blood Institute2009–2011
  • Characterization Of Hiv-1-Specific T Helper Cell ClonesNational Institute Of Allergy And Infectious Diseases2003–2004
  • Characterization Of Hiv-1-Specific T Helper Cell ClonesNational Institute Of Allergy And Infectious Diseases2000–2003

Hospital Affiliations